Transplantation, AutologousHematopoietic Stem Cell TransplantationMelphalanStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationCombined Modality TherapyTransplantation, HomologousBone MarrowTransplantation ConditioningTreatment OutcomeBone Marrow CellsRemission InductionCyclophosphamideDisease-Free SurvivalSalvage TherapyEtoposideStem CellsLymphoma, Non-HodgkinHodgkin DiseaseMyeloablative AgonistsCytarabineCarmustineRecurrenceSurvival RateBone Marrow PurgingThiotepaSurvival AnalysisDoxorubicinVincristineGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematopoietic Stem CellsAntineoplastic AgentsWhole-Body IrradiationAntineoplastic Agents, AlkylatingPrognosisHematologic NeoplasmsBusulfanLymphoma, Mantle-CellBoronic AcidsRetrospective StudiesPyrazinesAmyloidosisDexamethasoneFollow-Up StudiesGraft SurvivalBone and BonesTime FactorsChemotherapy, AdjuvantAntigens, CD34ThalidomideAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularPrednisoneGranulocyte Colony-Stimulating FactorLymphoma, T-Cell, PeripheralIfosfamideLymphomaLeukemia, Myeloid, AcuteCisplatinInduction ChemotherapyAutograftsNeoplasm, ResidualLiver TransplantationMesenchymal Stem Cell TransplantationTransplantation ChimeraLeukapheresisPodophyllotoxinMaintenance ChemotherapyLymphoma, Large B-Cell, DiffuseCarboplatinTissue DonorsDrug Administration ScheduleMyelodysplastic SyndromesLeukemia, MyeloidLymphoma, B-CellAntibodies, MonoclonalProspective StudiesHematopoiesisCell DifferentiationCord Blood Stem Cell TransplantationLeukemiaNeoplasm Recurrence, LocalCell TransplantationMitoxantroneNeoplasmsBone Marrow DiseasesNeoplasm StagingBreast NeoplasmsDose-Response Relationship, DrugPrecursor Cell Lymphoblastic Leukemia-LymphomaIdarubicinNeoplasms, Second PrimaryLeukemia, Plasma CellKidney TransplantationEmbryonic Stem CellsAcute Disease